PVLA

Palvella Therapeutics
PVLA

Overview Fund Trends Analyst Outlook Journalist POV

21 hedge funds and large institutions have $3.58M invested in Palvella Therapeutics in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 12 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 19

Holders
21
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$10.6K
2
+$9.52K
3
+$2.37K
4
US Bancorp
US Bancorp
Minnesota
+$285
5
BlackRock
BlackRock
New York
+$49

Top Sellers

1
-$650K
2
-$332K
3
-$177K
4
CM
CM Management
Florida
-$105K
5
Renaissance Technologies
Renaissance Technologies
New York
-$62.8K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
–
27
–
28
–
29
–
30
–
31
–
32
–
33
–
34
–
35
–
36
–
37
–
38
–
39
–
1
2